Compound ID | 186

Update compound information

Lefamulin

Synonym(s): Xenleta  |  BC-3781

Class: Pleuromutilin

Spectrum of activity: Gram-positive
Details of activity: BC‑7013 is a topical pleuromutilin antibiotic ready against gram-positive infections
Institute where first reported: Nabriva Therapeutics, Austria
Year first mentioned: 2010
Highest developmental phase: Approved by FDA in 2019
Development status: Active
External links:
Guide to Pharmacology: BC-7013
Main Source: https://www.nabriva.com/Portals/_default/Skins/ProfessionalUs/pdfs/extended-spectrum-pleuromutilins-mode-of-action-studies.pdf
Citations:
  • https://www.nabriva.com/Portals/_default/Skins/ProfessionalUs/pdfs/2009-%20antibacterial-spectrum-%20bc-3205.pdf
  • http://www.nabriva.com/programs/development/

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us.

    Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.